eSense-Lab signs deal with U.S cannabis concentrate producer

eSense-Lab (ASX:ESE) has signed a memorandum of understanding (MoU) with U.S. cannabis concentrate producer, Wild Rogue Extracts LLC.

Wild Rogue is a boutique cannabis concentrate producer and developer of cannabis essential oils, located in Oregon, U.S.

Under the terms of the MoU, eSense and Wild Rogue will collaborate in the development and marketing of a new line of cannabidiol (CBD) based products.

These will include vapors and vape pens (oils and concentrates), tinctures, salves and other topical applications and concentrates.

Wild Rogue will purchase initial quantities of eSense’s terpene profiles for development purposes, with a definitive agreement to be finalised the post-development phase.

Terpenes are organic compounds found in plants responsible for flavour and fragrance, along with many health and medical benefits.

Headquartered in Israel, esense has developed a proprietary plant profiling technology that can reconstruct the terpene profile of plants, using alternate natural sources.

As per the MoU, esense and Wild Rogue will retain their respective intellectual property (IP), with consideration to share any future jointly developed IP.

Wild Rogue will market eSense’s existing terpene profiles to its clients, and will be entitled to certain commissions in the event of sales from any introductions, to be detailed in a definitive agreement.

eSense shall also provide Wild Rogue with ongoing advice to improve Wild Rogue’s growing capabilities of cannabis plants.

Story by ProactiveInvestors